These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 29128558

  • 21. Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study.
    Perna G, Cocchi S, Bertani A, Arancio C, Bellodi L.
    J Clin Psychopharmacol; 1994 Dec; 14(6):414-8. PubMed ID: 7884022
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
    Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS.
    JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
    [Abstract] [Full Text] [Related]

  • 23. CO2 challenge induced HPA axis activation in panic.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):797-804. PubMed ID: 17076937
    [Abstract] [Full Text] [Related]

  • 24. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H, Verburg K, Hauzer R, Meijer J, Griez E.
    Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779
    [Abstract] [Full Text] [Related]

  • 25. Effects of 7.5% CO2 challenge in generalized anxiety disorder.
    Seddon K, Morris K, Bailey J, Potokar J, Rich A, Wilson S, Bettica P, Nutt DJ.
    J Psychopharmacol; 2011 Jan 01; 25(1):43-51. PubMed ID: 20233897
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
    Lindley SE, Carlson EB, Hill K.
    J Clin Psychopharmacol; 2007 Dec 01; 27(6):677-81. PubMed ID: 18004136
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The 35% CO2 challenge test in patients with social phobia.
    Caldirola D, Perna G, Arancio C, Bertani A, Bellodi L.
    Psychiatry Res; 1997 Jun 16; 71(1):41-8. PubMed ID: 9247980
    [Abstract] [Full Text] [Related]

  • 33. CO2 challenge of patients with panic disorder.
    Fyer MR, Uy J, Martinez J, Goetz R, Klein DF, Fyer A, Liebowitz MR, Gorman J.
    Am J Psychiatry; 1987 Aug 16; 144(8):1080-2. PubMed ID: 3111280
    [Abstract] [Full Text] [Related]

  • 34. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder.
    Heresco-Levy U, Vass A, Bloch B, Wolosker H, Dumin E, Balan L, Deutsch L, Kremer I.
    Int J Neuropsychopharmacol; 2009 Oct 16; 12(9):1275-82. PubMed ID: 19366490
    [Abstract] [Full Text] [Related]

  • 35. The effects of opioid receptor blockade on experimental panic provocation with CO2.
    Esquivel G, Fernández-Torre O, Schruers KR, Wijnhoven LL, Griez EJ.
    J Psychopharmacol; 2009 Nov 16; 23(8):975-8. PubMed ID: 18635711
    [Abstract] [Full Text] [Related]

  • 36. Effect of nicotine on 35% CO2-induced anxiety: A study in healthy volunteers.
    Cosci F, Abrams K, Schruers KR, Rickelt J, Griez EJ.
    Nicotine Tob Res; 2006 Aug 16; 8(4):511-7. PubMed ID: 16920648
    [Abstract] [Full Text] [Related]

  • 37. Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients.
    Wichmann S, Kirschbaum C, Böhme C, Petrowski K.
    Psychoneuroendocrinology; 2017 Sep 16; 83():135-141. PubMed ID: 28623762
    [Abstract] [Full Text] [Related]

  • 38. Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.
    Woods SW, Charney DS, Goodman WK, Heninger GR.
    Arch Gen Psychiatry; 1988 Jan 16; 45(1):43-52. PubMed ID: 3122696
    [Abstract] [Full Text] [Related]

  • 39. Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.
    Bailey JE, Argyropoulos SV, Kendrick AH, Nutt DJ.
    Depress Anxiety; 2005 Jan 16; 21(1):18-25. PubMed ID: 15782425
    [Abstract] [Full Text] [Related]

  • 40. The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study.
    Bertani A, Caldirola D, Bussi R, Bellodi L, Perna G.
    J Clin Psychopharmacol; 2001 Jun 16; 21(3):262-7. PubMed ID: 11386488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.